Ten63 is a drug discovery company that utilizes a proprietary drug discovery engine called BEYOND. This engine combines physics and AI in search algorithms to pursue biological targets for therapeutic research.

Ten63

Ten63 Therapeutics is focused on improving human health by developing better, more durable therapeutics against cancer and some of the world’s most lethal diseases. We are leveraging our proprietary in silico platform BEYOND to generate novel therapeutics to hit previously undruggable targets while bringing the paradigm of durable response into early drug design through our unique ability to predict and overcome drug resistance. 

We are hiring. 
At Ten63, we want a better world with healthier people! We value passion, teamwork, out of the box thinking and determination to solve even what seems impossible. We embrace diversity and are committed towards inclusion. If you think you have what it takes to be a part of out team, please apply. 


IndieBio

SOSV

Adam Morley

Morpheus Ventures

Alexandria Venture Investments

Sigma Group

Hatteras Venture Partners

Draper Associates

Ten63 Therapeutics

🌟 What an incredible week we just had at Ten63 Therapeutics! 🌟 

      Our week-long all-hands event was a blend of impactful discussions and                  engaging team-building activities. Throughout the week the Ten63 team         engaged in deep dives into our science, strategic planning sessions and fun  activities that strengthened team dynamics. We explored innovative approaches  and solidified strategies that bring us closer to making our mission to ensure no                                     patient is out of options when facing diseases like cancer a reality. 

                  Here's to the next chapter of innovation and success! 🚀 💡

We are growing our biology team at Ten63 Therapeutics. If you are a talented junior scientist come work alongside our VP of Biology Dr.Charlie Holst and our great team of scientist to discovery groundbreaking therapeutics against cancer.

We are looking for a great data engineer to help advance our fight against cancer. If that's you, please apply.

msh id	COM:TEN63TX
symbol	-
name	Ten63
homepage url	https://www.ten63tx.com
country	US
sector	Healthcare & Health Services
industry	Biotechnology
market	PRIVATE
employee count	25
crunchbase url	-
linkedin url	https://www.linkedin.com/company/gavilan-biodesign
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

TEN6

COM:TEN63TX

Ten63

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-